Skip to content

Efficacy evaluation of auricular acupuncture in the treatment of pregnancy nausea and vomiting: A protocol of randomized controlled trial

Efficacy evaluation of auricular acupuncture in the treatment of pregnancy nausea and vomiting: A protocol of randomized controlled trial

Status
Unknown
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220627007
Enrollment
43
Registered
2022-06-27
Start date
2022-08-21
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy nausea and vomiting are common symptoms during pregnancy, which seriously affects the quality of life of pregnant women. Intravenous infusion therapy is a common treatment for pregnancy vomiting, but the clinical effect is not good. There is evidence that auricular acupuncture has a positive effect on nausea and vomiting during pregnancy, but high-quality clinical studies have been lacking. Therefore, the purpose of this randomized controlled trial is to evaluate the efficacy and safet

Interventions

Treatment group: auricular acupuncture therapy: we will alternately select Shenmen (TF4), Wei (CO4), Jiaogan (AH6a), Neifenmi (CO18), Pizhixia (AT4) of the left and right ears as the operation sites,
Experimental Other

Sponsors

Ya Zou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Patients consistent with the diagnosis of pregnancy nausea and vomiting 2.Age: 18 to 40 years old; 3. Patients who has positive urine pregnancy test4. Patients with intrauterine pregnancy showed by B ultrasound5.Patients with 7 to 14 weeks of gestation.

Exclusion criteria

Exclusion criteria: 1. Patients who had a history of severe nausea and vomiting before pregnancy2. Patients with gastroenteritis, biliary tract infection, hepatitis, appendicitis and other diseases3. Patients with serious systemic diseases, such as diabetes, cardiovascular diseases, etc4.Patients allergy to test drug or tool.

Design outcomes

Primary

MeasureTime frame
Pregnancy-Unique Quantification of Emesis and Nausea,(PUQE) 7 days PUQE scale is divided into three dimensions, namely nausea, vomiting and retching.

Secondary

MeasureTime frame
Mental state score 7 days Self-rating Anxiety Scale (SAS) score;Self-rating Depression Scale (SDS) score

Countries

China

Contacts

Public ContactWei Nan

School of Medicine, University of Electronic Science and Technology of China

weinan0423@163.com18780370759

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026